Gastrointestinal hormonal dysfunction in gastroparesis and functional dyspepsia

Neurogastroenterology and Motility

Volumn 22, Issue 12, 2010, Pages 1270-1278

  Khoo, J ^a   Rayner, C K ^a   Feinle Bisset, C ^a   Jones, K L ^a   Horowitz, M ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cholecystokinin; Diabetes; Gastroparesis; Ghrelin; Glucagon like peptide 1; Peptide YY

Indexed keywords

ALEMCINAL; ATROPINE; CHOLECYSTOKININ; DEXLOXIGLUMIDE; EXENDIN 4; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; MITEMCINAL; MOTILIN; PEPTIDE YY;

ABDOMINAL PAIN; APPETITE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; DYSPEPSIA; EPIGASTRIC FULLNESS; EPIGASTRIC PAIN; FEEDING DISORDER; FUNCTIONAL DYSPEPSIA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HORMONE ACTION; HUMAN; HYPERSENSITIVITY; INSULIN DEPENDENT DIABETES MELLITUS; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH PARESIS;

ADIPOSE TISSUE; BLOOD GLUCOSE; CHOLECYSTOKININ; CRITICAL ILLNESS; DIABETES MELLITUS; DYSPEPSIA; GASTRIC EMPTYING; GASTROPARESIS; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; PEPTIDE YY; POSTPRANDIAL PERIOD;

EID: 78349287726     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01609.x     Document Type: Review

References (57)

1. Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association Technical Review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 1592-622.
2. Brener W, Hendrix TR, McHugh PR. Regulation of the gastric emptying of glucose. Gastroenterology 1983; 85: 76-82.
3. Elias E, Gibson GJ, Greenwood LF, Hunt JN, Tripp JH. The slowing of gastric emptying by monosaccharides and disaccharides in test meals. J Physiol (Lond) 1968; 194: 317-26.
4. Sanger G, Lee K. Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders. Nat Rev Drug Discov 2008; 7: 241-54.
5. Krishna AY, Blevins LS Jr. Case report: reversible gastroparesis in patients with hypopituitary disease. Am J Med Sci 1996; 312: 43-5.
6. Valenzuela G, Davis T Jr, McGroarty D, Pizzani E, Zfass A. Primary adrenal insufficiency: a new cause of reversible gastric stasis. Am J Gastroenterol 1990; 85: 1626-8.
7. Kahraman H, Kaya N, Demircali A, Bernay I, Tanyeri F. Gastric emptying time in patients with primary hypothyroidism. Eur J Gastroenterol Hepatol 1997; 9: 901-4.
8. Murphy KG, Dhillo WS, Bloom SR. Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev 2006; 27: 719-27.
9. Tack J, Lee KJ. Pathophysiology and treatment of functional dyspepsia. J Clin Gastroenterol 2005; 39: S211-6.
10. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia. Gastroenterology 2001; 121: 526-35.
11. Schwartz MP, Samsom M, Smout AJ. Chemospecific alterations in duodenal perception and motor response in functional dyspepsia. Am J Gastroenterol 2001; 96: 2596-602.
12. Pilichiewicz AN, Horowitz M, Holtmann GJ, Talley NJ, Feinle-Bisset C. Relationship between symptoms and dietary patterns in patients with functional dyspepsia. Clin Gastroenterol Hepatol 2009; 7: 317-22.
13. Pilichiewicz AN, Feltrin KL, Horowitz M et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol 2008; 103: 2613-23.
14. Feinle C, Rades T, Otto B, Fried M. Fat digestion modulates gastrointestinal sensations induced by gastric distension and duodenal lipid in humans. Gastroenterology 2001; 120: 1100-7.
15. Feinle C, Grundy D, Fried M. Modulation of gastric distension-induced sensations by small intestinal receptors. Am J Physiol 2001; 280: G51-7.
16. Chua AS, Keeling PW. Cholecystokinin hyperresponsiveness in functional dyspepsia. World J Gastroenterol 2006; 12: 2688-93.
17. McCallum RW, Cynshi O. Investigative Team. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. Aliment Pharmacol Ther 2007; 26: 1121-30.
18. Talley NJ, Verlinden M, Snape W et al. Failure of a motilin receptor antagonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000; 14: 1653-61.
19. Lanzini A, Magni P, Petroni ML et al. Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet. Aliment Pharmacol Ther 2006; 23: 907-13.
20. Akamizu T, Iwakura H, Ariyasu H et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol 2008; 158: 491-8.
21. Ejskjaer N, Dimcevski G, Wo J et al. Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study. Neurogastroenterol Motil 2010; 22: 1069-e281.
22. Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 675-80.
23. Schvarcz E, Palmér M, Aman J, Horowitz M, Stridsberg M, Berne C. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 1997; 113: 60-6.
24. Russo A, Stevens JE, Chen R et al. Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes. J Clin Endocrinol Metab 2005; 90: 4489-95.
25. Kuo P, Gentilcore D, Nair N et al. The nitric oxide synthase inhibitor, Ng-nitro-L-arginine-methyl-ester, attenuates the delay in gastric emptying induced by hyperglycemia in healthy humans. Neurogastroenterol Motil 2009; 21: 1175-e103.
26. Yeap BB, Russo A, Fraser RJ, Wittert GA, Horowitz M. Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects. Diabetes Care 1996; 19: 880-2.
27. Monnier L, Lapinski H, Colette C et al. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c. Diabetes Care 2003; 26: 881-5.
28. Horowitz M, Edelbroek MA, Wishart JM. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 1993; 36: 857-62.
29. Jones KL, Horowitz M, Carney BJ. Gastric emptying in early non-insulin diabetes mellitus. J Nucl Med 1996; 37: 1643-8.
30. Woerle HJ, Albrecht M, Linke R et al. Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans. Am J Physiol Endocrinol Metab 2008; 294: E103-9.
31. Gonlachanvit S, Hsu CW, Boden GH et al. Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients. Dig Dis Sci 2003; 48: 488-97.
32. Pilichiewicz A, O'Donovan D, Feinle C et al. Effect of lipase inhibition on gastric emptying of, and the glycemic and incretin responses to, an oil/aqueous drink in type 2 diabetes mellitus. J Clin Endocrinol Metab 2003; 88: 3829-34.
33. Kuo P, Stevens JE, Bellon M et al. Acute effects of pancreatic enzyme replacement on gastric emptying and postprandial glycemia in patients with cystic fibrosis (Abstract). Gastroenterology 2009; 136(5 Suppl. 1): P-272.
34. Pilichiewicz AN, Papadopoulos P, Brennan IM et al. Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab 2007; 293: E743-53.
35. Rayner CK, Ma J, Pilichiewicz A et al. Effects of variations in duodenal glucose load on glycemia, insulin and GLP-1 in type 2 diabetes. Diabetologia 2009; 52: S106.
36. Vilsboll T, Holst JJ. Incretins, insulin secretion and type 2 diabetes mellitus. Diabetologia 2004; 47: 357-66.
37. Vollmer K, Holst JJ, Baller B et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008; 57: 678-87.
38. Deane AM, Nguyen NQ, Stevens JE et al. Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia. J Clin Endocrinol Metab 2010; 95: 2115-21.
39. Schirra J, Nicolaus M, Roggel P et al. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans. Gut 2006; 55: 243-51.
40. Little TJ, Doran S, Meyer JH et al. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses. J Clin Endocrinol Metab 2006; 91: 1916-23.
41. Willms B, Werner J, Ørskov C, Holst JJ, Creutzfeldt W, Nauck MA. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2-(noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab 1996; 81: 327-32.
42. Meier JJ, Goetze O, Anstipp J et al. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans. Am J Physiol Endocrinol Metab 2004; 286: e621-5.
43. Ishii M, Nakamura T, Kasai F, Onuma T, Baba T, Takebe K. Altered postprandial insulin requirement in IDDM patients with gastroparesis. Diabetes Care 1994; 17: 901-3.
44. Harsch IA, Koebnick C, Tasi AM, Hahn EG, Konturek PC. Ghrelin and obestatin levels with type 2 diabetic patients with and without delayed gastric emptying. Dig Dis Sci 2009; 54: 2161-6.
45. Lysy J, Israeli E, Strauss-Liviatan N, Goldin E. Relationships between hypoglycemia and gastric emptying abnormalities in insulin-treated diabetic patients. Neurogastroenterol Motil 2006; 18: 433-40.
46. Andersen JH, Brunelle RL, Kolvisto A et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin analog treatment. Diabetes 1997; 46: 265-70.
47. Gentilcore D, Chaikomin R, Jones KL et al. Effects of fat on gastric emptying of, and the glycemic, insulin and incretin responses to, a carbohydrate meaI in type 2 diabetes. J Clin Endocrinol Metab 2006; 91: 2062-7.
48. Ma J, Stevens JE, Cukier K et al. Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care 2009; 32: 1600-2.
49. Linnebjerg H, Park S, Kothare PA et al. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regul Pept 2008; 151: 123-9.
50. Drucker DJ, Buse JB, Taylor K et al. DURATION-1 Study Group. Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet 2008; 372: 1240-50.
51. Chapman M, Fraser R, Vozzo R et al. Antro-pyloro-duodenal motor responses to gastric and duodenal nutrient in critically ill patients. Gut 2005; 54: 1384-90.
52. Nguyen NQ, Fraser RJ, Chapman M et al. Feed intolerance in critical illness is associated with increased basal and nutrient-stimulated plasma cholecystokinin concentrations. Crit Care Med 2007; 35: 82-8.
53. Nguyen NQ, Fraser RJL, Chapman M et al. Fasting and nutrient-stimulated plasma peptide-YY levels are elevated in critical illness and associated with feed intolerance: an observational, controlled study. Crit Care 2006; 10: R175.
54. Nguyen NQ, Fraser RJ, Bryant LK et al. The relationship between gastric emptying, plasma cholecystokinin and peptide YY in critically ill patients. Crit Care 2007; 11: R132.
55. Nguyen NQ, Chapman M, Bellon M et al. The role of 13C-octanoic acid breath testing in the assessment of gastric emptying in critically ill patients. Gastroenterology 2006; 130: A247.
56. Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Roguski K, Borowiec M. Disturbed release of gastrointestinal peptides in anorexia nervosa and obesity. Diabetes Obes Metab 2000; 2: 99-103.
57. McDermott J, Leslie F, D'Amato M, Thompson DG, Grencis R, McLaughlin JT. Immune control of food intake: enteroendocrine cells are regulated by CD4+ T lymphocytes during small intestinal inflammation. Gut 2006; 55: 492-7.